BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36077559)

  • 1. TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway.
    Gu H; Zhu S; Peng C; Wei Z; Shen Y; Yuan C; Yang H; Cui H; Yang L
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance.
    Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N
    Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway.
    Han S; Zhen W; Guo T; Zou J; Li F
    J Exp Clin Cancer Res; 2020 Oct; 39(1):218. PubMed ID: 33059737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.
    Li M; Gao F; Li X; Gan Y; Han S; Yu X; Liu H; Li W
    Cell Death Dis; 2022 Dec; 13(12):1053. PubMed ID: 36535926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis.
    Wang Y; Luo X; Wu N; Liao Q; Wang J
    J Cancer Res Ther; 2023 Feb; 19(1):97-107. PubMed ID: 37006049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway.
    Wang Y; Luo X; Wu N; Liao Q; Wang J
    Med Oncol; 2023 Jan; 40(2):76. PubMed ID: 36625999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
    Zhu L; Zhang S; Huan X; Mei Y; Yang H
    Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF4 promotes tumorigenesis of breast cancer through activation of Akt.
    Zhang J; Li X; Yang W; Jiang X; Li N
    Oncol Rep; 2014 Sep; 32(3):1312-8. PubMed ID: 24993240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ligase TRAF4 promotes IGF signaling by mediating atypical ubiquitination of IRS-1.
    Yu W; Singh R; Wang Z; O'Malley BW; Yi P
    J Biol Chem; 2021; 296():100739. PubMed ID: 33991522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.
    Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
    Oncol Res; 2014; 22(1):21-28. PubMed ID: 25700355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells.
    Wang X; Jin C; Tang Y; Tang LY; Zhang YE
    J Biol Chem; 2013 Jul; 288(30):21784-92. PubMed ID: 23760265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis.
    Shi C; Rao C; Sun C; Yu L; Zhou X; Hua D; Wang R; Luo W; Jiang Z; Zhou J; Wang Q; Yu S
    Cell Death Dis; 2018 Oct; 9(11):1078. PubMed ID: 30348972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
    Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
    J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling.
    Liu Y; Duan N; Duan S
    Biomed Res Int; 2018; 2018():2461363. PubMed ID: 30186853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance.
    Liao J; Qing X; Li X; Gan Y; Wang R; Han S; Li W; Song W
    Int J Biol Sci; 2024; 20(1):182-199. PubMed ID: 38164179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF4 positively regulates the osteogenic differentiation of mesenchymal stem cells by acting as an E3 ubiquitin ligase to degrade Smurf2.
    Li J; Wang P; Xie Z; Wang S; Cen S; Li M; Liu W; Tang S; Ye G; Zheng G; Su H; Ma M; Wu X; Wu Y; Shen H
    Cell Death Differ; 2019 Dec; 26(12):2652-2666. PubMed ID: 31076633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.
    Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S
    Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling.
    Iyengar PV; Marvin DL; Lama D; Tan TZ; Suriyamurthy S; Xie F; van Dinther M; Mei H; Verma CS; Zhang L; Ritsma L; Ten Dijke P
    Mol Cancer Res; 2022 Oct; 20(10):1516-1531. PubMed ID: 35731212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
    Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
    Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.